Search research articles
Contact Us
Filters
Showing results (341-350 of 431) with videos related to
Page
of 44
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 8, 2017
The Expansion of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva Is Activin A-Dependent
Jaymin Upadhyay, LiQin Xie, Lily Huang, et al.
European Heart Journal
|
June 29, 2017
TRAK2, a novel regulator of ABCA1 expression, cholesterol efflux and HDL biogenesis
Nicole J Lake, Rachael L Taylor, Hugh Trahair, et al.
Elife
|
June 10, 2020
Activin A forms a non-signaling complex with ACVR1 and type II Activin/BMP receptors via its finger 2 tip loop
Senem Aykul, Richard A Corpina, Erich J Goebel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 17, 2021
Cell type-selective targeted delivery of a recombinant lysosomal enzyme for enzyme therapies
Andrew D Baik, Philip Calafati, Xiaoli Zhang, et al.
Science Immunology
|
November 4, 2018
<b>Combination cancer immunotherapy targeting PD-1 and GITR can rescue CD8</b>
Bei Wang, Wen Zhang, Vladimir Jankovic, et al.
Haematologica
|
October 27, 2018
Chronic sympathetic driven hypertension promotes atherosclerosis by enhancing hematopoiesis
Annas Al-Sharea, Man K S Lee, Alexandra Whillas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 14, 2021
Late-onset kidney failure in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study
Bryan V Dieffenbach, Qi Liu, Andrew J Murphy, et al.
Science Translational Medicine
|
September 4, 2015
ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A
Sarah J Hatsell, Vincent Idone, Dana M Alessi Wolken, et al.
Circulation
|
January 17, 2020
Neutrophil-Derived S100A8/A9 Amplify Granulopoiesis After Myocardial Infarction
Gopalkrishna Sreejit, Ahmed Abdel-Latif, Baskaran Athmanathan, et al.
Science Translational Medicine
|
December 13, 2023
A therapeutic strategy to target distinct sources of IgE and durably reverse allergy
Andre Limnander, Navneet Kaur, Seblewongel Asrat, et al.
Page
of 44
Search research articles
Search
Showing results (341-350 of 431) with videos related to
Sort By:
Page
of 44
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 8, 2017
The Expansion of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva Is Activin A-Dependent
Jaymin Upadhyay, LiQin Xie, Lily Huang, et al.
European Heart Journal
|
June 29, 2017
TRAK2, a novel regulator of ABCA1 expression, cholesterol efflux and HDL biogenesis
Nicole J Lake, Rachael L Taylor, Hugh Trahair, et al.
Elife
|
June 10, 2020
Activin A forms a non-signaling complex with ACVR1 and type II Activin/BMP receptors via its finger 2 tip loop
Senem Aykul, Richard A Corpina, Erich J Goebel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 17, 2021
Cell type-selective targeted delivery of a recombinant lysosomal enzyme for enzyme therapies
Andrew D Baik, Philip Calafati, Xiaoli Zhang, et al.
Science Immunology
|
November 4, 2018
<b>Combination cancer immunotherapy targeting PD-1 and GITR can rescue CD8</b>
Bei Wang, Wen Zhang, Vladimir Jankovic, et al.
Haematologica
|
October 27, 2018
Chronic sympathetic driven hypertension promotes atherosclerosis by enhancing hematopoiesis
Annas Al-Sharea, Man K S Lee, Alexandra Whillas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 14, 2021
Late-onset kidney failure in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study
Bryan V Dieffenbach, Qi Liu, Andrew J Murphy, et al.
Science Translational Medicine
|
September 4, 2015
ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A
Sarah J Hatsell, Vincent Idone, Dana M Alessi Wolken, et al.
Circulation
|
January 17, 2020
Neutrophil-Derived S100A8/A9 Amplify Granulopoiesis After Myocardial Infarction
Gopalkrishna Sreejit, Ahmed Abdel-Latif, Baskaran Athmanathan, et al.
Science Translational Medicine
|
December 13, 2023
A therapeutic strategy to target distinct sources of IgE and durably reverse allergy
Andre Limnander, Navneet Kaur, Seblewongel Asrat, et al.
Page
of 44